This study, called "The Avenues Study," is looking for the best ways to help people who use both cigarettes and electronic cigarettes (vapes) quit smoking. It will test different approaches, including two medications: varenicline (a pill) and nicotine patches. It will also compare two types of counseling: one that helps you quit both smoking and vaping, and another that focuses on quitting smoking while using vaping to help reduce harm. You can join if you are 21 or older, speak English, smoke at least 5 cigarettes daily, vape weekly, and are willing to set a quit date for smoking within 30 days. The main goal is to see how many people successfully quit smoking for at least 7 days, confirmed by a test, up to 52 weeks after starting the study. The study plans to enroll 500 participants, but its current status is unclear.

Study design

This is a randomized study that will enroll 500 participants. It will compare different combinations of medications and counseling approaches.

What's involved

You will be on the study for 12 months. You will take either varenicline or nicotine patches, and participate in either one or four counseling sessions.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be checked for up to 52 weeks after you start the study to see if you have quit smoking.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.